We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Impossible Foods Stock

Invest in or calculate the value of your shares in Impossible Foods or other pre-IPO companies through EquityZen, part of Morgan Stanley.

Get Started

Impossible Foods Stock (IMPF)

Impossible Foods uses a scientific approach to create plant-based alternatives to meat and dairy products.They focus on identifying the key molecules that contribute to the sensory experience of meat consumption. These molecules are then recreated using plant-based ingredients and other nutrients.

Impossible Foods, Inc. develops plant-based substitutes for meat and dairy products. According to the company, it observes animal products at the molecular level, and selects specific proteins and nutrients from greens, seeds, and grains to recreate meats and dairy products. The company's first product is the Impossible Burger, which is made from ingredients including plant-based protein, coconut oil, and heme, among other ingredients. In January 2019, the company unveiled the Impossible Burger 2.0, which swaps out whey protein for soy protein. Impossible Foods makes heme from plants. Currently, the Impossible Burger is not available online but can be found in over 17,000 restaurants and over 150 grocery stores in the U.S., Hong Kong, Macau, and Singapore. In October 2019, the Impossible Burger launched in grocery stores nationwide, becoming the No. 1 item sold at Gelson's in California.

About Impossible Foods Stock

Founded

2011

Headquarters

Redwood City, CA, US

Total Funding

2.4B

Industries

Health Care, Food and Beverage

Impossible Foods, Inc. is the developer of plant-based substitutes for meat and dairy products. The company observes animal products at the molecular level and selects specific proteins and nutrients from greens, seeds, and grains to recreate meats and dairy products. The company's flagship product is the Impossible Burger, which they claim is made from ingredients including plant-based protein, coconut oil, and heme, among other ingredients. Heme is a protein found in animal muscle and is, according to the company, responsible for the characteristic taste and aroma of meat.

The company was incorporated in 2011 and is based in Redwood City, California. Notable investors in Impossible Foods include Temasek, Bill Gates, GV, Khosla Ventures, and Li Ka-Shing.

Investors in Impossible Foods

Discover investors in Impossible Foods stock and explore their portfolio companies

Impossible Foods Management

Leadership team at Impossible Foods

Chief Supply Chain Officer

Robert Haas

Chief Legal and Administrative Officer

Jason Gao

Locked Features

Join now and verify your accreditation status to gain access to:

  • Impossible Foods Current Valuation
  • Impossible Foods Stock Price
  • Impossible Foods Management
  • Available deals in Impossible Foods and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Impossible Foods Cap Table and Funding History by Share Class and Liquidity Preferences
    • Impossible Foods Revenue and Financials
    • Impossible Foods Highlights
    • Impossible Foods Business Model
    • Impossible Foods Risk Factors
  • Impossible Foods Research Report from SACRA Research
Join Now

Impossible Foods Key Facts

  • Strategic IP Portfolio Consolidation: In September 2024, Impossible Foods completed a strategic acquisition of Motif FoodWorks' heme-related business. This acquisition resolved a multi-year patent dispute and significantly strengthened Impossible Foods' core intellectual property and proprietary technology around heme, the iron-containing molecule responsible for replicating animal meat's distinct flavor and cooking characteristics.
  • Targeted Brand Repositioning & Consumer Expansion: Impossible Foods executed a brand overhaul designed to pivot away from eco-centric marketing toward "craveability" and culinary appeal. By repositioning its brand identity and packaging, the company seeks to expand its total addressable market beyond core vegans and vegetarians to capture the 100 million U.S. flexitarian consumers who periodically consume animal protein.
  • Retail & Foodservice Portfolio Diversification: Despite macro category headwinds in retail plant-based protein, Impossible Foods continues to expand its physical reach and product offerings. The company expanded its retail channel footprint, including securing a key distribution partnership for its chicken product lineup at Whole Foods Market, while entering high-demand seasonal categories such as plant-based hot dogs to drive recurring household penetration.


  • Losing Key Trademark Litigation: In March 2026, a federal jury in California ruled against Impossible Foods in a 5-year trademark lawsuit, finding that Impossible Foods "willfully and maliciously infringed" two registered "IMPOSSIBLE" trademarks. The court awarded $3.25 million in total damages, including $1.75 million in punitive damages, and subsequently ordered Impossible Foods to pay millions in additional legal fees due to its weak defense strategies. This outcome hurts the company’s legal positioning, adds direct financial burdens, and creates potential restrictions on how it uses the "Impossible" brand for media, recipes, and merchandise.
  • Sustained Industry Downturn and Strategic Shift: The plant-based meat sector continues to face headwinds as retail demand cools, causing private equity funding in the sector to drop by 64% to $309 million. Impossible Foods CEO, Peter McGuinness revealed the company is considering launching a blended hybrid burger (50% plant, 50% beef) to attract broader consumer segments. Blended animal proteins risks alienating core vegan and vegetarian consumers while demonstrating the operational challenge of scaling pure plant-based alternatives.
  • Regulatory Shift toward Ultra-Processed Foods Scrutiny: In mid-2025 into 2026, regulatory bodies, such as the FDA, and health policy agendas, such as the "MAHA" movement, have increased focus on establishing explicit definitions for "ultra-processed foods" and implementing front-of-pack nutrition labeling rules. Heightened public and regulatory scrutiny puts pressure on the company to reformulate its products or face shifting consumer sentiment.


Trading Impossible Foods Stock

How to invest in Impossible Foods stock?

Accredited investors can buy pre-IPO stock in companies like Impossible Foods through EquityZen funds. These investments are made available by existing Impossible Foods shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.

How to sell Impossible Foods stock?

Shareholders can sell their Impossible Foods stock through EquityZen's private company marketplace. EquityZen's network includes over 470K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 56K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."